Feasibility of using PRESAGE®for relative 3D dosimetry of small proton fields

Li Zhao, Joseph Newton, Mark Oldham, Indra J. Das, Chee Wai Cheng, John Adamovics

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Small field dosimetry is challenging due to the finite size of the conventional detectors that underestimate the dose distribution. With the fast development of the dynamic proton beam delivery system, it is essential to find a dosimeter which can be used for 3D dosimetry of small proton fields. We investigated the feasibility of using a proton formula PRESAGE®for 3D dosimetry of small fields in a uniform scanning proton beam delivery system with dose layer stacking technology. The relationship between optical density and the absorbed dose was found to be linear through small volume cuvette studies for both photon and proton irradiation. Two circular fields and three patient-specific fields were used for proton treatment planning calculation and beam delivery. The measured results were compared with the calculated results in the form of lateral dose profiles, depth dose, isodose plots and gamma index analysis. For the circular field study, lateral dose profile comparison showed that the relative PRESAGE®profile falls within ± 5% from the calculated profile for most of the spatial range. For unmodulated depth dose comparison, the agreement between the measured and calculated results was within 3% in the beam entrance region before the Bragg peak. However, at the Bragg peak, there was about 20% underestimation of the absorbed dose from PRESAGE®. For patient-specific field 3D dosimetry, most of the data points within the target volume passed gamma analysis for 3% relative dose difference and 3mm distance to agreement criteria. Our results suggest that this proton formula PRESAGE®dosimeter has the potential for 3D dosimetry of small fields in proton therapy, but further investigation is needed to improve the dose under-response of the PRESAGE®in the Bragg peak region.

Original languageEnglish
JournalPhysics in Medicine and Biology
Volume57
Issue number22
DOIs
StatePublished - Nov 21 2012

Fingerprint

Protons
Proton Therapy
Photons
Technology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Feasibility of using PRESAGE®for relative 3D dosimetry of small proton fields. / Zhao, Li; Newton, Joseph; Oldham, Mark; Das, Indra J.; Cheng, Chee Wai; Adamovics, John.

In: Physics in Medicine and Biology, Vol. 57, No. 22, 21.11.2012.

Research output: Contribution to journalArticle

Zhao, Li ; Newton, Joseph ; Oldham, Mark ; Das, Indra J. ; Cheng, Chee Wai ; Adamovics, John. / Feasibility of using PRESAGE®for relative 3D dosimetry of small proton fields. In: Physics in Medicine and Biology. 2012 ; Vol. 57, No. 22.
@article{4287472937e14eec8453dc8b09aac327,
title = "Feasibility of using PRESAGE{\circledR}for relative 3D dosimetry of small proton fields",
abstract = "Small field dosimetry is challenging due to the finite size of the conventional detectors that underestimate the dose distribution. With the fast development of the dynamic proton beam delivery system, it is essential to find a dosimeter which can be used for 3D dosimetry of small proton fields. We investigated the feasibility of using a proton formula PRESAGE{\circledR}for 3D dosimetry of small fields in a uniform scanning proton beam delivery system with dose layer stacking technology. The relationship between optical density and the absorbed dose was found to be linear through small volume cuvette studies for both photon and proton irradiation. Two circular fields and three patient-specific fields were used for proton treatment planning calculation and beam delivery. The measured results were compared with the calculated results in the form of lateral dose profiles, depth dose, isodose plots and gamma index analysis. For the circular field study, lateral dose profile comparison showed that the relative PRESAGE{\circledR}profile falls within ± 5{\%} from the calculated profile for most of the spatial range. For unmodulated depth dose comparison, the agreement between the measured and calculated results was within 3{\%} in the beam entrance region before the Bragg peak. However, at the Bragg peak, there was about 20{\%} underestimation of the absorbed dose from PRESAGE{\circledR}. For patient-specific field 3D dosimetry, most of the data points within the target volume passed gamma analysis for 3{\%} relative dose difference and 3mm distance to agreement criteria. Our results suggest that this proton formula PRESAGE{\circledR}dosimeter has the potential for 3D dosimetry of small fields in proton therapy, but further investigation is needed to improve the dose under-response of the PRESAGE{\circledR}in the Bragg peak region.",
author = "Li Zhao and Joseph Newton and Mark Oldham and Das, {Indra J.} and Cheng, {Chee Wai} and John Adamovics",
year = "2012",
month = "11",
day = "21",
doi = "10.1088/0031-9155/57/22/N431",
language = "English",
volume = "57",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "22",

}

TY - JOUR

T1 - Feasibility of using PRESAGE®for relative 3D dosimetry of small proton fields

AU - Zhao, Li

AU - Newton, Joseph

AU - Oldham, Mark

AU - Das, Indra J.

AU - Cheng, Chee Wai

AU - Adamovics, John

PY - 2012/11/21

Y1 - 2012/11/21

N2 - Small field dosimetry is challenging due to the finite size of the conventional detectors that underestimate the dose distribution. With the fast development of the dynamic proton beam delivery system, it is essential to find a dosimeter which can be used for 3D dosimetry of small proton fields. We investigated the feasibility of using a proton formula PRESAGE®for 3D dosimetry of small fields in a uniform scanning proton beam delivery system with dose layer stacking technology. The relationship between optical density and the absorbed dose was found to be linear through small volume cuvette studies for both photon and proton irradiation. Two circular fields and three patient-specific fields were used for proton treatment planning calculation and beam delivery. The measured results were compared with the calculated results in the form of lateral dose profiles, depth dose, isodose plots and gamma index analysis. For the circular field study, lateral dose profile comparison showed that the relative PRESAGE®profile falls within ± 5% from the calculated profile for most of the spatial range. For unmodulated depth dose comparison, the agreement between the measured and calculated results was within 3% in the beam entrance region before the Bragg peak. However, at the Bragg peak, there was about 20% underestimation of the absorbed dose from PRESAGE®. For patient-specific field 3D dosimetry, most of the data points within the target volume passed gamma analysis for 3% relative dose difference and 3mm distance to agreement criteria. Our results suggest that this proton formula PRESAGE®dosimeter has the potential for 3D dosimetry of small fields in proton therapy, but further investigation is needed to improve the dose under-response of the PRESAGE®in the Bragg peak region.

AB - Small field dosimetry is challenging due to the finite size of the conventional detectors that underestimate the dose distribution. With the fast development of the dynamic proton beam delivery system, it is essential to find a dosimeter which can be used for 3D dosimetry of small proton fields. We investigated the feasibility of using a proton formula PRESAGE®for 3D dosimetry of small fields in a uniform scanning proton beam delivery system with dose layer stacking technology. The relationship between optical density and the absorbed dose was found to be linear through small volume cuvette studies for both photon and proton irradiation. Two circular fields and three patient-specific fields were used for proton treatment planning calculation and beam delivery. The measured results were compared with the calculated results in the form of lateral dose profiles, depth dose, isodose plots and gamma index analysis. For the circular field study, lateral dose profile comparison showed that the relative PRESAGE®profile falls within ± 5% from the calculated profile for most of the spatial range. For unmodulated depth dose comparison, the agreement between the measured and calculated results was within 3% in the beam entrance region before the Bragg peak. However, at the Bragg peak, there was about 20% underestimation of the absorbed dose from PRESAGE®. For patient-specific field 3D dosimetry, most of the data points within the target volume passed gamma analysis for 3% relative dose difference and 3mm distance to agreement criteria. Our results suggest that this proton formula PRESAGE®dosimeter has the potential for 3D dosimetry of small fields in proton therapy, but further investigation is needed to improve the dose under-response of the PRESAGE®in the Bragg peak region.

UR - http://www.scopus.com/inward/record.url?scp=84869034689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869034689&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/57/22/N431

DO - 10.1088/0031-9155/57/22/N431

M3 - Article

VL - 57

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 22

ER -